Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study

被引:12
作者
Butnoriene, Jurate [1 ]
Steibliene, Vesta [2 ]
Saudargiene, Ausra [3 ,4 ]
Bunevicius, Adomas [4 ]
机构
[1] Lithuanian Univ Hlth Sci, Inst Endocrinol, Eiveniu Str 2, LT-50161 Kaunas, Lithuania
[2] Lithuanian Univ Hlth Sci, Psychiat Clin, Kaunas, Lithuania
[3] Lithuanian Univ Hlth Sci, Kaunas, Lithuania
[4] Lithuanian Univ Hlth Sci, Neurosci Inst, Kaunas, Lithuania
关键词
Depressive disorder; General anxiety disorder; Hospital anxiety and depression scale; Metabolic syndrome; Mini international neuropsychiatric interview; Screening; GENERALIZED ANXIETY; PRIMARY-CARE; HOSPITAL ANXIETY; DSM-IV; PSYCHIATRIC MORBIDITY; MOOD DISORDERS; FOLLOW-UP; PREVALENCE; COMORBIDITY; SCALE;
D O I
10.1186/s12888-017-1576-8
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Depressive and anxiety disorders are common in primary care setting but often remain undiagnosed. Metabolic syndrome (MetS) is also prevalent in the general population and can impair recognition of common mental disorders due to significant co-morbidity and overlap with psychiatric symptoms included in self-reported depression/anxiety screening tools. We investigated if MetS has an impact on the accuracy of current major depressive disorder (MDD) and generalized anxiety disorder (GAD) screening results using the Hospital Anxiety and Depression scale (HADS). Methods: A total of 1115 (562 men; mean age 62.0 +/- 9.6 years) individuals of 45+ years of age were randomly selected from the general population and evaluated for current MetS; depressive and anxiety symptoms (HADS); and current MDD and GAD (Mini International Neuropsychiatric Interview [MINI]). Results: The MetS was diagnosed in 34.4% of the study participants. Current MDD and GAD were more common in individuals with MetS relative to individuals without MetS (25.3% vs 14.2%, respectively, p < 0.001; and 30.2% vs 20.9%, respectively, p < 0.001). The ROC analyses demonstrated that optimal thresholds of the HADS-Depression subscale for current MDE were >= 9 in individuals with MetS (sensitivity >= 87%, specificity = 73% and PPV = 52%) and >= 8 in individuals without MetS (sensitivity = 81%, specificity = 78% and PPV = 38%). At threshold of = 9 the HADS-Anxiety subscale demonstrated optimal psychometric properties for current GAD screening in individuals with MetS (sensitivity = 91%, specificity = 85% and PPV = 72%) and without MetS (sensitivity = 84%, specificity = 83% and PPV = 56%). Conclusions: The HADS is a reliable screening tool for current MDE and GAD in middle aged and elderly population with and without MetS. Optimal thresholds of the HADS-Depression subscale for current MDD is >= 9 for individuals with MetS and >= 8 - without MetS. Optimal threshold of the HADS-Anxiety subscale is >= 9 for current GAD in individuals with and without MetS. The presence of MetS should be considered when interpreting depression screening results.
引用
收藏
页数:10
相关论文
共 73 条
  • [31] An evaluation of two self-report screening measures for mood in an out-patient chronic heart failure population
    Haworth, J. E.
    Moniz-Cook, E.
    Clark, A. L.
    Wang, M.
    Cleland, J. G. F.
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 22 (11) : 1147 - 1153
  • [32] Metabolic syndrome and depression:: A cross-sectional analysis
    Heiskanen, Tuula H.
    Niskanen, Leo K.
    Hintikka, Jukka J.
    Koivumaa-Honkanen, Heli T.
    Honkalampi, Kirsi M.
    Haatainen, Kaisa M.
    Viinamaki, Heimo T.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (09) : 1422 - 1427
  • [33] SCREENING FOR PSYCHIATRIC MORBIDITY IN PATIENTS WITH ADVANCED BREAST-CANCER - VALIDATION OF 2 SELF-REPORT QUESTIONNAIRES
    HOPWOOD, P
    HOWELL, A
    MAGUIRE, P
    [J]. BRITISH JOURNAL OF CANCER, 1991, 64 (02) : 353 - 356
  • [34] Recommendations on screening for depression in adults
    Joffres, Michel
    Jaramillo, Alejandra
    Dickinson, James
    Lewin, Gabriela
    Pottie, Kevin
    Shaw, Elizabeth
    Gorber, Sarah Connor
    Tonelli, Marcello
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2013, 185 (09) : 775 - 782
  • [35] Metabolic syndrome: definitions and controversies
    Kassi, Eva
    Pervanidou, Panagiota
    Kaltsas, Gregory
    Chrousos, George
    [J]. BMC MEDICINE, 2011, 9
  • [36] Anxiety disorders: Efficient screening is the first step in improving outcomes
    Katon, Wayne
    Roy-Byrne, Peter
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (05) : 390 - 391
  • [37] Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes
    Katsuki, A
    Sumida, Y
    Gabazza, EC
    Murashima, S
    Furuta, M
    Araki-Sasaki, R
    Hori, Y
    Yano, Y
    Adachi, Y
    [J]. DIABETES CARE, 2001, 24 (02) : 362 - 365
  • [38] A Comprehensive Review on Metabolic Syndrome
    Kaur, Jaspinder
    [J]. CARDIOLOGY RESEARCH AND PRACTICE, 2014, 2014
  • [39] The categorical versus dimensional assessment controversy in the sociology of mental illness
    Kessler, RC
    [J]. JOURNAL OF HEALTH AND SOCIAL BEHAVIOR, 2002, 43 (02) : 171 - 188
  • [40] The epidemiology of generalized anxiety disorder
    Kessler, RC
    Keller, MB
    Wittchen, HU
    [J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 2001, 24 (01) : 19 - +